189 related articles for article (PubMed ID: 17145627)
1. Hepatitis C-associated granulomas after liver transplantation: morphologic spectrum and clinical implications.
Vakiani E; Hunt KK; Mazziotta RM; Emond JC; Brown RS; Lefkowitch JH; Bhagat G
Am J Clin Pathol; 2007 Jan; 127(1):128-34. PubMed ID: 17145627
[TBL] [Abstract][Full Text] [Related]
2. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
[TBL] [Abstract][Full Text] [Related]
3. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
Saraf N; Fiel MI; Deboccardo G; Emre S; Schiano TD
Liver Transpl; 2007 Jun; 13(6):913-7. PubMed ID: 17539015
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
Fiel MI; Agarwal K; Stanca C; Elhajj N; Kontorinis N; Thung SN; Schiano TD
Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
7. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of hepatitis C virus reinfection after liver transplantation.
Powers KA; Ribeiro RM; Patel K; Pianko S; Nyberg L; Pockros P; Conrad AJ; McHutchison J; Perelson AS
Liver Transpl; 2006 Feb; 12(2):207-16. PubMed ID: 16447184
[TBL] [Abstract][Full Text] [Related]
9. Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients.
Ferrell LD; Lee R; Brixko C; Bass NM; Lake JR; Roberts JP; Ascher N; Rabkin J
Transplantation; 1995 Nov; 60(9):926-33. PubMed ID: 7491695
[TBL] [Abstract][Full Text] [Related]
10. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
[TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
12. Epitheloid granuloma formation in type C chronic hepatitis: report of two cases.
Yamamoto S; Iguchi Y; Ohomoto K; Mitsui Y; Shimabara M; Mikami Y
Hepatogastroenterology; 1995 Jul; 42(3):291-3. PubMed ID: 7590582
[TBL] [Abstract][Full Text] [Related]
13. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts.
Borgogna C; Toniutto P; Smirne C; Azzimonti B; Rittà M; Avellini C; Fabris C; Landolfo S; Gariglio M; Pirisi M
Histopathology; 2009 Jun; 54(7):837-46. PubMed ID: 19635103
[TBL] [Abstract][Full Text] [Related]
14. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.
Dharancy S; Podevin P; Aoudjehane L; Batteux F; Rosenberg AR; Soubrane O; Calmus Y; Conti F
Transplantation; 2007 Apr; 83(7):906-11. PubMed ID: 17460561
[TBL] [Abstract][Full Text] [Related]
15. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
16. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
18. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
[TBL] [Abstract][Full Text] [Related]
19. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
20. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.
Bahra M; Jacob D; Neumann UP; Spies F; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
Transplantation; 2007 Jul; 84(2):144-8. PubMed ID: 17667804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
